ADGM

Adagio Medical Holdings, Inc.

$1.84

-4.17%
SectorHealthcareIndustryMedical DevicesCountryUnited States

Adagio Medical Holdings, Inc., a medical technology company, focuses on the development and commercialization of ablation technologies for the treatment of cardiac arrhythmias. It offers treatment for cardiac arrhythmias, including atrial fibrillation, and ventricular tachycardia. The company's product portfolio includes iCLAS atrial ultra-low temperature ablation (ULTA) catheter and system; vCLAS ventricular ULTC catheter; and Cryopulse pulsed field cryoablation catheters. Adagio Medical Holdings, Inc. was founded in 2011 and is headquartered in Laguna Hills, California.

Source: Yahoo Finance
AI summary

Price & performance

1M-52.8%
3M-91.8%
YTD-94.3%
1Y-92.9%
52-week range—
Beta1.11
Full chart and returns against a benchmark

Q-Score

—/ 100

Quality against peers; 50 is the peer median.

Growth—
Risk25
Performance22
Valuation—
Profitability—
Leverage42
Sentiment52
Every score and metric

News sentiment

Open News

Latest results · FY 2025

Revenue—
Net income-$25.1M
Net margin—
Historical fundamentals

Red flags in filings

2active red flags
Going-concern doubtMar 27, 2026
Exchange listing noticeAug 14, 2026
Filings, findings and the timeline

Revenue exposure

Regions, segments, customers and suppliers

Valuation

ADGMIndustryP/E—29.61P/S—3.49EV/EBITDA—18.38P/B—3.39PEG——
Dividend yield0.00%
Every valuation metric